Earnings Feed
Start Free
BIOJECT MEDICAL TECHNOLOGIES INC·4

Jan 2, 7:01 PM ET

Makar Ralph 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jan 2, 2009

Insider Transaction Report

Form 4
Period: 2008-12-31
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
Makar Ralph
DirectorCEO/President
Transactions
  • Exercise/Conversion

    BJCT Common Stock

    [F1]
    2008-12-31+50,000→ 295,701 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F2][F3][F4]
    2008-12-31−50,000→ 390,934 total
    From: 2008-12-31→ BJCT Common Stock (50,000 underlying)
Holdings

  • BJCT Common Stock

    (indirect: By 401(k))
    15,441
Footnotes (4)
  • [F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
  • [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F3]No expiration date.
  • [F4]Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 166,667.
Signature
//Christine M. Farrell Attorney-in-Fact for Ralph Makar//|2009-01-02

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT